Rifapentin
From Wikipedia, the free encyclopedia
| Image:Rifapentin.png | |
|
Rifapentin
|
|
| Systematic (IUPAC) name | |
| 3{[(4-cyclopentyl-1-piperazinyl) imino]methyl} rifamycin | |
| Identifiers | |
| CAS number | 61379-65-5 |
| ATC code | J04AB05 |
| PubChem | 5462354 |
| DrugBank | APRD01217 |
| Chemical data | |
| Formula | C47H64N4O12 |
| Mol. weight | 877.031 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Rifapentin (or rifapentine) is an antibiotic used in the treatment of tuberculosis.
 |
This medical article is a stub. You can help Wikipedia by expanding it. |
| Antimycobacterials (J04) edit | ||
|---|---|---|
| Tuberculosis: |
Aminosalicylic acid, Calcium aminosalicylate, Capreomycin, Cycloserine, Ethambutol, Ethionamide, Isoniazid, Morinamide, Protionamide, Pyrazinamide, Rifabutin, Rifampicin, Rifamycin, Rifapentin, Sodium aminosalicylate, Terizidone, Tiocarlide |
|
| Leprosy: | ||
